Review Stimuli-responsive nanomaterials for wound healing: advances and emerging directions Full text PDF
Research Paper Converting focused ultrasound–based boiling histotripsy into a systemic cancer vaccine using antigen-capturing microparticles Full text PDF
Research Paper BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage–myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis Full text PDF
Research Paper First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493) Full text PDF
Review Integrating the hallmarks of cancer into autophagy: a perspective from underlying mechanisms to therapeutic strategies Full text PDF
Research Paper Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality Full text PDF
Issue 10; 2026
Founding Editor-in-Chief:
Prof. Xiaoyuan (Shawn) Chen, PhD
Profile
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
Rationale: Carbonic Anhydrase IX (CAIX) positron emission tomography (PET) is an accurate and non-invasive imaging modality for the detection and characterisation of clear-cell renal cell carcinoma (ccRCC) but evidence in the setting of high-risk renal cancer is lacking. We conducted an exploratory investigation to integrate whole-body CAIX-PET imaging with tissue-level validation and to assess the potential impact of CAIX-PET on systemic staging ...